During the early stages of type 1 diabetes mellitus (T1DM), the seroconversion of islet-specific autoantibodies—targeting insulin, glutamate decarboxylase, insulinoma-associated antigen 2, or zinc transporter 8—represents the earliest notable indicator of autoimmune activity. This evidence concerns the gene INS and diabetes mellitus.